Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 10/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Memory impairment, Pain, Presyncope
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1602JPN012445
Write-up:Initial information has been received from a physician concerning a female patient (age unknown) who was intramuscularly vaccinated with GARDASIL injection drug (vaccinated date and dose indication). No information including underlying/concomitant disease and medical history was obtained. No other concomitant medication was reported. On an unknown date, the patient was intramuscularly vaccinated with recombinant GARDASIL intramuscular injection syringe for the first time. The patient had an episode of suspected memory impairment. On an unknown date, the patient was intramuscularly vaccinated with GARDASIL for the second time. The patient had an episode of suspected memory impairment. On an unknown date, the patient was intramuscularly vaccinated with GARDASIL for the third time. The patient had an episode of suspected memory impairment and pain like she was about to faint. At the time of the report on 24-FEB-2016, the outcome of memory impairment and pain was unknown. Reporter''s comment: It was unknown if the patient was vaccinated with GARDASIL or CERVARIX. The reporting physician considered that memory impairment was serious due to disability. The reporting physician considered pain as non-serious. The reporting physician did not assess the causal relationship of memory impairment and pain to GARDASIL. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166